Evogene Ltd. — Form SCHEDULE 13D/A
Filed September 11, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 15/100
What the filing says
A Schedule 13D/A (amended beneficial ownership statement) was filed on 2026-09-11 regarding Evogene Ltd. (agricultural chemicals company, CIK 0001574565). The filer is listed as an entity at Medinat Hayehudim Street, Herzelia. The actual amendment details—specific ownership percentages, share counts, counterparty identity, or what changed from the original 13D—are not provided in this header/index text.
Why this rating
Schedule 13D/A is routine disclosure; no substantive amendment details disclosed in filing text. Cannot assess materiality without ownership % or share data.
See more from September 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.